BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sawas T, Alsawas M, Bazerbachi F, Iyer PG, Wang KK, Murad MH, Katzka DA. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett’s esophagus increases the risk of dysplasia recurrence: meta-analysis. Gastrointestinal Endoscopy 2019;89:913-925.e6. [DOI: 10.1016/j.gie.2018.11.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Desai M, Rösch T, Sundaram S, Chandrasekar VT, Kohli D, Spadaccini M, Hassan C, Repici A, Sharma P. Systematic review with meta-analysis: the long-term efficacy of Barrett's endoscopic therapy-stringent selection criteria and a proposal for definitions. Aliment Pharmacol Ther 2021;54:222-33. [PMID: 34165205 DOI: 10.1111/apt.16473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Codipilly DC, Dhaliwal L, Oberoi M, Gandhi P, Johnson ML, Lansing RM, Harmsen WS, Wang KK, Iyer PG. Comparative Outcomes of Cap Assisted Endoscopic Resection and Endoscopic Submucosal Dissection in Dysplastic Barrett's Esophagus. Clin Gastroenterol Hepatol 2022;20:65-73.e1. [PMID: 33220523 DOI: 10.1016/j.cgh.2020.11.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
4 Dhaliwal L, Iyer PG. State of the Art: Management of Barrett’s Esophagus Related Dysplasia and Neoplasia—Which Patient and What Therapy? Foregut 2021;1:68-77. [DOI: 10.1177/2634516121993260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Solfisburg QS, Sami SS, Gabre J, Soroush A, Dhaliwal L, Beveridge C, Jin Z, Poneros JM, Falk GW, Ginsberg GG, Wang KK, Lightdale CJ, Iyer PG, Abrams JA. Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2021;93:1250-1257.e3. [PMID: 33144238 DOI: 10.1016/j.gie.2020.10.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wani S, Gyawali CP, Katzka DA. AGA Clinical Practice Update on Reducing Rates of Post-Endoscopy Esophageal Adenocarcinoma: Commentary. Gastroenterology 2020;159:1533-7. [DOI: 10.1053/j.gastro.2020.06.089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, van Hooft JE, Deprez PH, Dinis-Ribeiro M. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy 2022. [PMID: 35523224 DOI: 10.1055/a-1811-7025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fasullo M, Shah T, Patel M, Mutha P, Zfass A, Lippman R, Smallfield G. Outcomes of Radiofrequency Ablation Compared to Liquid Nitrogen Spray Cryotherapy for the Eradication of Dysplasia in Barrett's Esophagus. Dig Dis Sci 2021. [PMID: 33954846 DOI: 10.1007/s10620-021-06991-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wani S, Yadlapati R, Singh S, Sawas T, Katzka DA; Post-Endoscopy Esophageal Neoplasia Expert Consensus Panel. Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel. Gastroenterology 2021:S0016-5085(21)03620-9. [PMID: 34655571 DOI: 10.1053/j.gastro.2021.09.067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shaheen NJ. Where is the finish line for endoscopic eradication therapy in Barrett's esophagus? Gastrointest Endosc 2019;89:926-8. [PMID: 31005132 DOI: 10.1016/j.gie.2019.01.017] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Kolb JM, Wani S. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Curr Opin Gastroenterol 2020;36:351-8. [PMID: 32487852 DOI: 10.1097/MOG.0000000000000650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]